ADVANCED BILIARY TRACT CARCINOMA
Clinical trials for ADVANCED BILIARY TRACT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BILIARY TRACT CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED BILIARY TRACT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise for tough liver and bile duct cancers
Disease control CompletedThis study tested a new combination treatment for people with advanced liver cancer or bile duct cancer. It used an immunotherapy drug (SHR-1210) plus either a targeted therapy (apatinib) or chemotherapy. The goal was to see if the combination was safe and could shrink tumors. 15…
Matched conditions: ADVANCED BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New combo shows promise for tough bile duct cancer
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and lenvatinib, in 27 people with advanced bile duct cancer that had stopped responding to standard treatments. The goal was to see if the combination could shrink tumors and control the disease. This is not a cure, but …
Matched conditions: ADVANCED BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Shanghai Jiahui International Hospital • Aim: Disease control
Last updated May 13, 2026 15:58 UTC